Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Saxenda
Saxenda
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk
BioSpace
Tue, 04/9/24 - 11:11 am
EMA
Europe
diabetes
weight loss
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Trulicity
Saxenda
Rybelsus
Victoza
Many patients keep weight off after stopping anti-obesity meds: study
Axios
Wed, 01/24/24 - 10:44 am
obesity
Novo Nordisk
Ozempic
Wegovy
Saxenda
Victoza
European regulators probe suicide risk to Ozempic, other Novo drug Saxenda
BioPharma Dive
Mon, 07/10/23 - 09:40 pm
Novo Nordisk
Ozempic
Saxenda
EMA
Europe
suicide
Novo Nordisk apologizes for not disclosing sponsorship of anti-obesity training
Financial Times
Mon, 02/13/23 - 10:44 am
Novo Nordisk
obesity
UK
Saxenda
A pharmaceutical jack of all trades? Novo CEO touts semaglutide's potential in NASH, Alzheimer's and its hot start in obesity
Fierce Pharma
Mon, 08/29/22 - 10:40 am
Novo Nordisk
semaglutide
NASH
Alzheimer's disease
Saxenda
obesity
Vivus’ Qsymia beats out weight loss competitors in pricing watchdog's latest cost-effectiveness analysis
Endpoints
Wed, 07/13/22 - 08:22 pm
Vivus
Qsymia
weight loss
ICER
Novo Nordisk
Saxenda
Wegovy
Novo Nordisk, citing strong Wegovy demand, doubles 2025 sales target for obesity franchise
Fierce Pharma
Thu, 03/3/22 - 10:54 am
Novo Nordisk
obesity
Wegovy
Saxenda
Insights into how Novo Nordisk's Saxenda cuts food cravings may inspire new obesity drugs
Fierce Biotech
Thu, 03/5/20 - 11:05 pm
Novo Nordisk
Saxenda
obesity
food cravings
NICE shuns Novo Nordisk's obesity med Saxenda, citing CV questions
Fierce Pharma
Sun, 01/26/20 - 01:40 pm
Novo Nordisk
Saxenda
UK
NICE
Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1
Fierce Pharma
Tue, 05/23/17 - 08:14 am
Novo Nordisk
Saxenda
Latin America
obesity
Novo Nordisk: Why The Diabetes Giant Will Continue To Grow
Seeking Alpha
Tue, 12/13/16 - 10:14 am
Novo Nordisk
diabetes
Tresiba
Saxenda
Victoza
Novo Nordisk: Make-And-Take Strategy For The Obesity Drug Market
Seeking Alpha
Wed, 12/30/15 - 06:55 pm
Novo Nordisk
obesity
Saxenda
Novo Nordisk: Has This Company Solved The Anti-Obesity Sector Woes?
Seeking Alpha
Tue, 09/29/15 - 08:58 am
Novo Nordisk
Saxenda
obesity
Canada
Novo Nordisk Launches Obesity Medication In Canada - How Did That Happen?
Seeking Alpha
Mon, 09/14/15 - 10:55 am
Novo Nordisk
obesity
Saxenda
Canada
drug launches
Novo Nordisk executive fuels firm's new obesity fight
Medical Marketing and Media
Tue, 05/26/15 - 10:46 am
Novo Nordisk
obesity
Saxenda
Jesper Høiland
What Novo Nordisk's Entry Into The Obesity Space Means To The Sector
Seeking Alpha
Fri, 04/24/15 - 11:03 am
Novo Nordisk
obesity
Saxenda
Eyeing big niche in obesity, Novo rolls out Saxenda at $1,000 per month
Fierce Pharma
Wed, 04/22/15 - 01:55 pm
Novo Nordisk
Saxenda
obesity
Novo Nordisk Quietly Becoming Big Player In Obesity Space
Seeking Alpha
Fri, 04/10/15 - 09:27 am
Novo Nordisk
obesity
Saxenda
How Novo Nordisk plans to keep its eyes on the diabetes prize
BioPharma Dive
Wed, 03/18/15 - 11:38 am
Novo Nordisk
diabetes
Saxenda
Novo Nordisk Readies For Saxenda Launch - Investors Need To Keep Expectations Realistic
Seeking Alpha
Tue, 03/10/15 - 08:28 am
Novo Nordisk
Saxenda
drug launches
Pages
1
2
next ›
last »